Moat Biotechnology

Oklahoma City, OK · Founded 2022 · Privately Held (backing)

Developer of oral vaccines designed to accelerate the treatment of infectious diseases. Moat Biotechnology is based in Oklahoma City, OK and was founded in 2022. Its last reported valuation was $56.5 million in Dec 2023. It has raised $8.2 million across 1 recorded round; the latest was a $1.5 million debt round in Jun 2022.

Last reported valuation
$56.5M
Oct 2026
Priced at
—
Total raised
$8.2M
Last round
Debt
Jun 2022
What is Moat Biotechnology worth?
$56.5Mlast reported valuation · Oct 2026

Moat Biotechnology's last reported valuation, Dec 2023. Nothing priced has surfaced since.

Free account
More of Moat Biotechnology with a free account
  • ·Watch Moat Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Moat Biotechnology funding history

1 rounds
DateRoundRaisedPost-money
Jun 2022Debt$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Moat Biotechnology valuation

Moat Biotechnology's last reported valuation was $56.5 million in Dec 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Moat Biotechnology raised?

Moat Biotechnology has raised $8.2 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million debt round in Jun 2022.

Moat Biotechnology has filed 3 Form Ds with the SEC since 2022, most recently in Feb 2023 ($101,640 sold to 2 investors).

How Moat Biotechnology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Moat Biotechnology, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Moat Biotechnology

What is Moat Biotechnology worth?
Moat Biotechnology is valued at $56.5M as of Oct 2026. Moat Biotechnology's last reported valuation, Dec 2023. Nothing priced has surfaced since.
How much has Moat Biotechnology raised?
Moat Biotechnology has raised $8.2M in total funding across 1 recorded rounds.
When did Moat Biotechnology last raise?
Moat Biotechnology last raised in Jun 2022 (Debt), raising $1.5M.